September 25, 2019
Strongbridge Biopharma plc to Present at the 2019 Cantor Global Healthcare Conference
Media
September 24, 2019
Targovax announces opening of Oslo University Hospital as site for ONCOS-102 trial in melanoma
September 23, 2019
GenSight Biologics reports sustained efficacy and safety at 96 weeks in RESCUE Phase III clinical trial of GS010 for the treatment of Leber Hereditary Optic Neuropathy (LHON)
September 19, 2019
Strongbridge Biopharma plc Announces RECORLEV™ (levoketoconazole) Phase 3 SONICS Data Published in The Lancet Diabetes & Endocrinology
September 18, 2019
BONESUPPORT HOLDING AB presents health economic evidence
September 17, 2019
Nordic Nanovector R&D Day unveils updates on several programs
September 16, 2019
Vicore Pharma publishes prospectus in connection with its listing on Nasdaq Stockholm
September 15, 2019
New Interim Data in RRMM Patients with Extramedullary Disease from the Pivotal Phase 2 Horizon-study presented at International Myeloma Workshop
September 12, 2019
Data from Oncopeptides Melflufen Clinical Development Program Presented at SOHO 2019 Annual Meeting
September 11, 2019
Vicore Pharma has been approved for listing on Nasdaq Stockholm
